Products

What will AGI do for Bisoprolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H31NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y41JS2NL6U, chemically known as 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)- but generally known as bisoprolol, which bears US NIH Compound Identifier 2405. Bisoprolol most often comes in base and fumarate forms. European Medicines Agency schedules Bisoprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13096MIG. The term BISOPROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules bisoprolol in its Anatomical Therapeutic Chemical (ATC) Classification. BISOPROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bisoprolol under HS 29221980 and SITC 51461. As of Q4 2014, BISOPROLOL remains the US FDA Preferred Term for this commodity. Bisoprolol bears US NLM identifiers UMLS ID C0053799 and NCI Concept Code C61653. SMILES: O(CC(O)CNC(C)C)C1CCC(COCCOC(C)C)CC1.